Determinants of adherence to treatment in patients with ophthalmic conditions

References

• Stevens GA, White RA, Flaxman SR, et al. Global prevalence of vision impairment and blindness. Ophthalmol. 2013;120:2377–2384. doi: 10.1016/j.ophtha.2013.05.025
   PubMed Web of Science ®Google Scholar
• Pezzullo L, Streatfeild J, Simkiss P, et al. The economic impact of sight loss and blindness in the UK adult population. BMC Health Serv Res. 2018;18:63. doi: 10.1186/s12913-018-2836-0
   PubMed Web of Science ®Google Scholar
• Steinmetz JD, Bourne RRA, Briant PS, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global burden of disease study. Lancet Glob Health. 2021;9:e144–60. doi: 10.1016/S2214-109X(20)30489-7
   PubMed Web of Science ®Google Scholar
• Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmol. 2014;121:2081–2090. doi: 10.1016/j.ophtha.2014.05.013
   PubMed Web of Science ®Google Scholar
• Hashemi H, Khabazkhoob M, Nabovati P, et al. The prevalence of age-related eye disease in an Elderly population. Ophthalmic Epidemiol. 2017;24:222–228. doi: 10.1080/09286586.2016.1270335
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Luo L-J, Yang C-J, et al. Highly retina-permeating and long-acting resveratrol/metformin nanotherapeutics for enhanced treatment of macular degeneration. ACS Nano. 2023;17:168–183. doi: 10.1021/acsnano.2c05824
   PubMed Web of Science ®Google Scholar
• Luo L-J, Nguyen DD, Lai J-Y. Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): methoxylation effects and pharmacological treatments of glaucoma-related neurodegeneration. JControlled Release. 2020;317:246–258. doi: 10.1016/j.jconrel.2019.11.038
   PubMed Web of Science ®Google Scholar
• Gómez-Aguayo F, Paczka JA, Leñero-Córdova R, et al. A phase III randomized clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide fixed combination, preservative-free ophthalmic solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide fixed combination in patients with controlled primary Open-angle glaucoma. Ophthalmol Ther. 2018;7:145–156. doi: 10.1007/s40123-018-0128-8
   PubMedGoogle Scholar
• Luo L-J, Nguyen DD, Lai J-Y. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy. Biomaterials. 2020;243:119961. doi: 10.1016/j.biomaterials.2020.119961
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, et al. Patterns of adherence behaviour for patients with glaucoma. Eye. 2013;27:545–553. doi: 10.1038/eye.2012.294
   PubMed Web of Science ®Google Scholar
• Meier-Gibbons F, Töteberg-Harms M. Influence of cost of care and adherence in glaucoma management: an update. J Ophthalmol. 2020;2020:1–5. doi: 10.1155/2020/5901537
   Web of Science ®Google Scholar
• Miura T, Kojima R, Mizutani M, et al. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57:77–83. doi: 10.1007/s002280100272
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44–47. doi: 10.1111/j.1524-4733.2007.00213.x
   PubMed Web of Science ®Google Scholar
• Cross AJ, Elliott RA, Petrie K, et al. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev. 2020;2020. doi: 10.1002/14651858.CD012419.pub2
   Google Scholar
• Bilger M, Wong TT, Lee JY, et al. Using adherence-contingent rebates on chronic disease treatment costs to promote medication adherence: results from a randomized controlled Trial. Appl Health Econ Health Policy. 2019;17:841–855. doi: 10.1007/s40258-019-00497-0
   PubMed Web of Science ®Google Scholar
• Kumamaru H, Lee MP, Choudhry NK, et al. Using Previous medication adherence to predict future adherence. J Manag Care Spec Pharm. 2018;24:1146–1155. doi: 10.18553/jmcp.2018.24.11.1146
   PubMed Web of Science ®Google Scholar
• Lo-Ciganic W-H, Donohue JM, Thorpe JM, et al. Using machine learning to examine medication adherence thresholds and risk of hospitalization. Med care. 2015;53:720–728. doi: 10.1097/MLR.0000000000000394
   PubMed Web of Science ®Google Scholar
• Sackett D, Gibson E, Taylor DW, et al. RANDOMISED CLINICAL TRIAL of STRATEGIES for IMPROVING MEDICATION COMPLIANCE in PRIMARY HYPERTENSION. Lancet. 1975;305:1205–1207. doi: 10.1016/S0140-6736(75)92192-3
   Google Scholar
• Costa VP, Aung T, Konstas AG. Evolution of the treatment paradigm for maximum medical therapy in glaucoma. Expert Rev Ophthalmol. 2019;14:33–42. doi: 10.1080/17469899.2019.1570138
   Web of Science ®Google Scholar
• Belalcázar-Rey S, Sánchez Huerta V, Ochoa-Tabares JC, et al. Efficacy and safety of sodium hyaluronate/chondroitin sulfate preservative-free ophthalmic solution in the treatment of dry eye: a clinical Trial. Curr Eye Res. 2021;46:919–929. doi: 10.1080/02713683.2020.1849733
   PubMed Web of Science ®Google Scholar
• Koesmahargyo V, Abbas A, Zhang L, et al. Accuracy of machine learning-based prediction of medication adherence in clinical research. Psychiatry Res. 2020;294:113558. doi: 10.1016/j.psychres.2020.113558
   PubMed Web of Science ®Google Scholar
• Wu X-W, Yang H-B, Yuan R, et al. Predictive models of medication non-adherence risks of patients with T2D based on multiple machine learning algorithms. BMJ Open Diabetes Res Care. 2020;8:e001055. doi: 10.1136/bmjdrc-2019-001055
   PubMed Web of Science ®Google Scholar
• Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22:313–356. doi: 10.1007/BF02850081
   PubMed Web of Science ®Google Scholar
• Otón T, Carmona L, Urruticoechea-Arana A, et al. Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs. Rheumatol Int. 2019;39:1077–1082. doi: 10.1007/s00296-019-04304-w
   PubMed Web of Science ®Google Scholar
• Westberg A, Sjölander M, Glader E-L, et al. Primary non-adherence to preventive drugs and associations with beliefs about medicines in stroke survivors. Patient Prefer Adherence. 2022;16:343–352. doi: 10.2147/PPA.S351001
   PubMed Web of Science ®Google Scholar
• Park KK, Choi CH, Ha C-W, et al. The effects of adherence to non-steroidal anti-inflammatory drugs and factors influencing drug adherence in patients with knee osteoarthritis. J Korean Med Sci. 2016;31:795. doi: 10.3346/jkms.2016.31.5.795
   PubMed Web of Science ®Google Scholar
• Marras C, Monteagudo I, Salvador G, et al. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the compliance questionnaire in rheumatology: an ARCO sub-study. Rheumatol Int. 2017;37:1195–1202. doi: 10.1007/s00296-017-3737-y
   PubMed Web of Science ®Google Scholar
• Schmid-Mohler G, Thut MP, Wüthrich RP, et al. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clin Transplant. 2010;24:213–222. doi: 10.1111/j.1399-0012.2009.01056.x
   PubMed Web of Science ®Google Scholar
• Zongo A, Simpson S, Johnson JA, et al. Change in trajectories of adherence to lipid‐lowering drugs following non‐fatal acute coronary syndrome or stroke. J Am Heart Assoc. 2019 8;8(23). doi: https://doi.org/10.1161/JAHA.119.013857
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, et al. A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial. Clin Trial. 2015;12:608–617. doi: 10.1177/1740774515592636
   PubMed Web of Science ®Google Scholar
• Erras A, Shahrvini B, Weinreb RN, et al. Review of glaucoma medication adherence monitoring in the digital health era. Br J Ophthalmol. 2023;107:153–159. doi: 10.1136/bjophthalmol-2020-317918
   PubMed Web of Science ®Google Scholar
• Harrington RA. Trials and tribulations of randomized clinical trials. Circulation. 2022;146:380–382. doi: 10.1161/CIRCULATIONAHA.122.060649
   PubMedGoogle Scholar
• Brooks KM, Castillo-Mancilla JR, Morrow M, et al. Adherence to direct-acting antiviral therapy in people actively using drugs and alcohol: the INCLUD study. Open Forum Infect Dis. 2021 8;8(1). doi: https://doi.org/10.1093/ofid/ofaa564
   Web of Science ®Google Scholar
• Mino-León D, Reyes-Morales H, Flores-Hernández S. Effectiveness of involving pharmacists in the process of ambulatory health care to improve drug treatment adherence and disease control. J Eval Clin Pract. 2015;21:7–12. doi: 10.1111/jep.12207
   PubMed Web of Science ®Google Scholar
• Cook J, Ramadas V. When to consult precision-recall curves. Stata J. 2020;20:131–148. doi: 10.1177/1536867X20909693
   Web of Science ®Google Scholar
• Brunner HI, Giannini EH. Trial design, measurement, and analysis of clinical investigations. In Textbook of pediatric rheumatology. Elsevier; 2011. p. 127–156. doi: 10.1016/B978-1-4160-6581-4.10007-X.
   Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35. doi: 10.1002/1097-0142(1950)3:1<32:AID-CNCR2820030106>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Gu Y, Zalkikar A, Liu M, et al. Predicting medication adherence using ensemble learning and deep learning models with large scale healthcare data. Sci Rep. 2021;11:18961. doi: 10.1038/s41598-021-98387-w
   PubMed Web of Science ®Google Scholar
• Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–1117. doi: 10.1136/bmj.39553.670231.25
   PubMed Web of Science ®Google Scholar
• Pedrosa-Naudín MA, Gutiérrez-Abejón E, Herrera-Gómez F, et al. Non-adherence to antidepressant treatment and related factors in a region of Spain: a population-based registry study. Pharmaceutics. 2022;14:2696. doi: 10.3390/pharmaceutics14122696
   PubMed Web of Science ®Google Scholar
• Pantuzza LL, Ceccato MDG, Silveira MR, et al. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73:1475–1489. doi: 10.1007/s00228-017-2315-2
   PubMed Web of Science ®Google Scholar
• Alves-Conceição V, Rocha KSS, Silva FVN, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54:301–313. doi: 10.1177/1060028019886846
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014. doi: 10.1002/14651858.CD000011.pub4
   PubMedGoogle Scholar
• Zhang Z, Peluso MJ, Gross CP, et al. Adherence reporting in randomized controlled trials. Clin Trial. 2014;11:195–204. doi: 10.1177/1740774513512565
   PubMed Web of Science ®Google Scholar
• Benedict C, Wang J, Reppucci M, et al. Cost of survivorship care and adherence to screening—aligning the priorities of health care systems and survivors. Transl Behav Med. 2021;11:132–142. doi: 10.1093/tbm/ibz182
   PubMed Web of Science ®Google Scholar
• Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and drug adherence in the elderly. Front Cardiovasc Med. 2020;7. doi: 10.3389/fcvm.2020.00049
   PubMed Web of Science ®Google Scholar
• Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35:539–545. doi: 10.1345/aph.10295
   PubMed Web of Science ®Google Scholar
• Boucquemont J, Pai ALH, Dharnidharka VR, et al. Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation. 2019;103:798–806. doi: 10.1097/TP.0000000000002359
   PubMed Web of Science ®Google Scholar
• Rolnick SJ, Pawloski PA, Hedblom BD, et al. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11:54–65. doi: 10.3121/cmr.2013.1113
   PubMedGoogle Scholar
• Allen CF, Simon Y, Edwards J, et al. Adherence to antiretroviral therapy by people accessing services from non-governmental HIV support organisations in three Caribbean countries. West Indian Med J. 2011;60:269–275.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Quintana Gallego E, Carrasco Hernández L. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503–1515. doi: 10.2147/COPD.S170848
   PubMed Web of Science ®Google Scholar
• Baiza-Durán LM, Muñoz-Villegas P, Sánchez-Ríos A, et al. Efficacy and safety of an ophthalmic DMPC-Based nanoemulsion in patients with dry eye disease: a phase I/II randomized clinical Trial. J Ophthalmol. 2023;2023:1–9. doi: 10.1155/2023/1431473
   Web of Science ®Google Scholar
• Azari AA, Barney NP. Conjunctivitis. JAMA. 2013;310:1721. doi: 10.1001/jama.2013.280318
   PubMed Web of Science ®Google Scholar
• Szaflik J, Szaflik JP, Kamińska A, et al. Clinical and microbiological Efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis. Eur J Ophthalmol. 2009;19:1–9. doi: 10.1177/112067210901900101
   PubMed Web of Science ®Google Scholar
• Tsioufis K, Castellano Vázquez JM, Sykara G, et al. Real-world evidence for adherence and persistence with atorvastatin therapy. Cardiol Ther. 2021;10:445–464. doi: 10.1007/s40119-021-00240-8
   PubMed Web of Science ®Google Scholar
• Chen C, Li X, Su Y, et al. Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence. Clin Cardiol. 2022;45:1220–1228. doi: 10.1002/clc.23898
   PubMed Web of Science ®Google Scholar
• Kim H-S, Lee S, Kim JH. Real-world evidence versus randomized controlled Trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):33. doi: https://doi.org/10.3346/jkms.2018.33.e213
   Web of Science ®Google Scholar
• Stephenson BJ. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779. doi: 10.1001/jama.1993.03500210079036
   PubMed Web of Science ®Google Scholar
• Tannenbaum SL, McClure LA, Zheng DD, et al. Ocular screening adherence across Hispanic/Latino heritage groups with diabetes: results from the ocular SOL ancillary to the Miami site of the hispanic community health study/study of latinos (HCHS/SOL). BMJ Open Diabetes Res Care. 2016;4:e000236. doi: 10.1136/bmjdrc-2016-000236
   PubMed Web of Science ®Google Scholar